Charles Flexner
Charles Williams Flexner is an American physician, clinical pharmaceutical scientist, academic, author and researcher. He is a Professor of Medicine at the Johns Hopkins University School of Medicine.Flexner's work is focused on the basic and clinical pharmacology of drugs for HIV/AIDS and related infections. He has published over 250 scientific manuscripts, reviews, and book chapters on the use of drugs for the treatment and prevention of HIV and other infectious diseases, this includes early studies of HIV protease inhibitors, and the use of accelerator mass spectrometry to determine drug disposition in humans. He has also authored several books and textbooks, including ''Protease Inhibitors in AIDS Therapy'', ''Integrative Pharmacology'', ''Antiretroviral Drug Interactions: A Practical Approach'', and ''2012 DDI: HIV Drug Interaction Guide.''
Flexner served as President of the ''American Federation for Medical Research (AFMR)'', and the ''AFMR Foundation''. Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Charles Flexner', query time: 0.03s
Refine Results
-
1
Ageing in patients with chronic HIV infection: impact of hypercoagulation by Stephen J. Kent, Charles Flexner
Published 2018-11-01
Article -
2
The Changing Face of HIV by Suzanne Willard Phd, Crnp, Faan, Charles Flexner MD
Published 2008-03-01
Article -
3
-
4
Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies by James J. Hobson, Amer Al-khouja, Paul Curley, David Meyers, Charles Flexner, Marco Siccardi, Andrew Owen, Caren Freel Meyers, Steve P. Rannard
Published 2019-03-01
Article -
5
Physiologically Based Pharmacokinetic Modelling of Cabotegravir Microarray Patches in Rats and Humans by Hannah Kinvig, Rajith K. R. Rajoli, Henry Pertinez, Lalitkumar K. Vora, Fabiana Volpe-Zanutto, Ryan F. Donnelly, Steve Rannard, Charles Flexner, Marco Siccardi, Andrew Owen
Published 2023-11-01
Article -
6
Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations by Paul Curley, James J. Hobson, Neill J. Liptrott, Edward Makarov, Amer Al-khouja, Lee Tatham, Christopher A. W. David, Helen Box, Megan Neary, Joanne Sharp, Henry Pertinez, David Meyers, Charles Flexner, Caren L. Freel Meyers, Larisa Poluektova, Steve Rannard, Andrew Owen
Published 2023-06-01
Article -
7
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. by Athe M N Tsibris, Bette Korber, Ramy Arnaout, Carsten Russ, Chien-Chi Lo, Thomas Leitner, Brian Gaschen, James Theiler, Roger Paredes, Zhaohui Su, Michael D Hughes, Roy M Gulick, Wayne Greaves, Eoin Coakley, Charles Flexner, Chad Nusbaum, Daniel R Kuritzkes
Published 2009-05-01
Article